Author:
Abdeladim Salma,Elharrass Mahassine,Bensahi Ilham,Elouarradi Amal,Sabry Mohamed
Publisher
Springer International Publishing
Reference108 articles.
1. Ababneh MA, Al-Azzam SI, Alzoubi KH, Rababa’h AM (2016) Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan. Int J Clin Pharm 38:816–821
2. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th edition. American college of chest physicians evidence-based clinical practice guidelines. Chest 141(Suppl 2):e44s–e88s
3. Alrashid MH, Al-Serri A, Alshemmari SH, Koshi P, Al-Bustan SA (2016) Association of genetic polymorphisms in the VKORC1 and CYP2C9 genes with warfarin dosage in a Group of Kuwaiti Individuals. Mol Diagn Ther 20(2):183–190
4. Al-Saikhan FI (2020) Warfarin therapy adherence and health-related quality of life among patients using warfarin in Saudi Arabia. Niger J Clin Pract 23:398–407
5. ALAmmari M, Alturaiki A, Althemery AU et al (2019) Factors associated with the use of warfarin and the risk of bleeding: cross-sectional study. Indo American Journal of Pharmaceutical Sciences: o6 pp. 7284–7291